These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 34206297)
21. Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro. Dratwa M; Wysoczanska B; Turlej E; Anisiewicz A; Maciejewska M; Wietrzyk J; Bogunia-Kubik K Exp Cell Res; 2020 Nov; 396(1):112298. PubMed ID: 32971118 [TBL] [Abstract][Full Text] [Related]
22. Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival. Ghaffari SH; Shayan-Asl N; Jamialahmadi AH; Alimoghaddam K; Ghavamzadeh A Ann Oncol; 2008 Nov; 19(11):1927-34. PubMed ID: 18567608 [TBL] [Abstract][Full Text] [Related]
23. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome. Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863 [TBL] [Abstract][Full Text] [Related]
24. Targeting human telomerase in cancer therapy. Huard S; Autexier C Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725 [TBL] [Abstract][Full Text] [Related]
25. Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia. Eskandari E; Hashemi M; Naderi M; Bahari G; Safdari V; Taheri M Asian Pac J Cancer Prev; 2018 Jun; 19(6):1515-1521. PubMed ID: 29936725 [TBL] [Abstract][Full Text] [Related]
26. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. Brennan SK; Wang Q; Tressler R; Harley C; Go N; Bassett E; Huff CA; Jones RJ; Matsui W PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824134 [TBL] [Abstract][Full Text] [Related]
27. Transient Telomerase Inhibition with Imetelstat Impacts DNA Damage Signals and Cell-Cycle Kinetics. Thompson CAH; Gu A; Yang SY; Mathew V; Fleisig HB; Wong JMY Mol Cancer Res; 2018 Aug; 16(8):1215-1225. PubMed ID: 29759988 [TBL] [Abstract][Full Text] [Related]
28. Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS. Li Y; Deng B; Ouyang N; Yuan P; Zheng L; Wang W J Assist Reprod Genet; 2017 Jul; 34(7):849-859. PubMed ID: 28477298 [TBL] [Abstract][Full Text] [Related]
29. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs. Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357 [TBL] [Abstract][Full Text] [Related]
31. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Franco S; Ozkaynak MF; Sandoval C; Tugal O; Jayabose S; Engelhardt M; Moore MA Leukemia; 2003 Feb; 17(2):401-10. PubMed ID: 12592340 [TBL] [Abstract][Full Text] [Related]
32. Telomerase activity, telomere length and hTERT DNA methylation in peripheral blood mononuclear cells from monozygotic twins with discordant smoking habits. Marcon F; Siniscalchi E; Andreoli C; Allione A; Fiorito G; Medda E; Guarrera S; Matullo G; Crebelli R Environ Mol Mutagen; 2017 Oct; 58(8):551-559. PubMed ID: 28843010 [TBL] [Abstract][Full Text] [Related]
33. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. Hu Y; Bobb D; He J; Hill DA; Dome JS Cancer Biol Ther; 2015; 16(6):949-57. PubMed ID: 25920748 [TBL] [Abstract][Full Text] [Related]
35. How to inhibit telomerase activity for cancer therapy. Kyo S; Inoue M Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells. Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503 [TBL] [Abstract][Full Text] [Related]
37. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Joseph I; Tressler R; Bassett E; Harley C; Buseman CM; Pattamatta P; Wright WE; Shay JW; Go NF Cancer Res; 2010 Nov; 70(22):9494-504. PubMed ID: 21062983 [TBL] [Abstract][Full Text] [Related]
38. Telomere biology of pediatric cancer. Tabori U; Dome JS Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490 [TBL] [Abstract][Full Text] [Related]
39. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. Burchett KM; Yan Y; Ouellette MM PLoS One; 2014; 9(1):e85155. PubMed ID: 24409321 [TBL] [Abstract][Full Text] [Related]
40. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors. Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]